Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. de Batlle, F. P. Gómez, J. Gea, M. Mendez, J. Ferrer, D. Donaire, E. Balcells, M. Orozco-Levi, J. M. Antó, J. Garcia-Aymerich (Barcelona, Bunyola, Spain). Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients. Eur Respir J 2010; 36: Suppl. 54, 3646

Member's Comments

No comment yet.

Related content which might interest you: Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004 Dietary and nutrient intake profile in Japanese COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005 The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Intake of antioxidants and n-3 and n-6 PUFA in relation to asthma and eczema in a cohort of pregnant women Source: Eur Respir J 2002; 20: Suppl. 38, 428s Year: 2002 Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007 Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006 Status of fat soluble vitamins in Scandinavian CF patients Source: Eur Respir J 2007; 30: Suppl. 51, 389s Year: 2007 Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010 The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006 Prenatal exposure to n-6/n-3 fatty acids, trace elements and minerals and risk of atopic disease in childhood: birth cohort study Source: Eur Respir J 2003; 22: Suppl. 45, 564s Year: 2003 Airway inflammation is augmented by obesity and fatty acids in asthma Source: Eur Respir J 2011; 38: 594-602 Year: 2011 Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003